This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Potential Role of β-Blockade

Richard A. Yeager, MD; Gregory L. Moneta, MD; James M. Edwards, MD; Lloyd M. Taylor, Jr, MD; Donald B. McConnell, MD; John M. Porter, MD

Arch Surg. 1995;130(8):869-873.

Abstract
Objective
To determine which perioperative variables may influence the occurrence of perioperative myocardial infarction (PMI) following vascular surgery.

Design
Case-contol study.

Setting
Combined Veterans Affairs Medical Centeruniversity hospital vascular service.

Patients
During a 4-year period, all major vascular surgical operations (N=2088) were evaluated with serial postoperative electrocardiography and cardiac enzyme measurements. Patients with PMI following nonemergent vascular surgery (N=53) were matched with randomly selected control patients without PMI (N=106) for age, gender, type of operation, hypertension, and symptoms of coronary artery disease.

Main Outcome Measures
The two groups were compared for operative blood loss, blood pressure, and heart rate as well as length of operation, type of anesthetic, and use of perioperative β-blockers, nitroglycerine, calcium channel blockers, vasopressors, and angiotensinconverting enzyme inhibitors.

Results
β-Blockers were used less frequently in patients with PMI than in control patients without PMI (30% vs 50%; P=.01). Overall β-blockade was associated with a 50% reduction in PMI (P=.03). Perioperative myocardial infarction was not associated with length of operation, type of anesthetic, blood pressure, or use of other medications.

Conclusions
β-Blockade is associated with a decreased incidence of PMI in patients undergoing vascular surgery. Prophylactic perioperative use of β-blockers may decrease PMI in patients requiring major vascular surgery. A prospective randomized trial of β-blockers in these patients appears to be warranted.

(Arch Surg. 1995;130:869-873)

Author Affiliations
From the Division of Vascular Surgery, Department of Surgery, Oregon Health Sciences University, Portland, and Portland Veterans Affairs Medical Center.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
American College of Cardiology Foundation et al.
J Am Coll Cardiol 2009;54:e13-e118.
FULL TEXT  

2009 ACCF/AHA Focused Update on Perioperative Beta Blockade
American College of Cardiology Foundation et al.
J Am Coll Cardiol 2009;54:2102-2128.
FULL TEXT  

2009 ACCF/AHA Focused Update on Perioperative Beta Blockade: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA et al.
Circulation 2009;120:2123-2151.
FULL TEXT  

2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
2007 WRITING COMMITTEE MEMBERS et al.
Circulation 2009;120:e169-e276.
FULL TEXT  

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery
Fleisher et al.
J Am Coll Cardiol 2007;50:e159-e242.
FULL TEXT  

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
Fleisher et al.
Circulation 2007;116:e418-e500.
FULL TEXT  

ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker Therapy -- A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
Fleisher et al.
Anesth. Analg. 2007;104:15-26.
ABSTRACT | FULL TEXT  

ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker Therapy: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology
Fleisher et al.
J Am Coll Cardiol 2006;47:2343-2355.
FULL TEXT  

Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: The Statins for Risk Reduction in Surgery (StaRRS) study
O'Neil-Callahan et al.
J Am Coll Cardiol 2005;45:336-342.
ABSTRACT | FULL TEXT  

Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology
Task Force Members et al.
Eur Heart J 2004;25:1341-1362.
FULL TEXT  

Priorities in Perioperative Geriatrics
Cook and Rooke
Anesth. Analg. 2003;96:1823-1836.
FULL TEXT  

Effect of preoperative {beta}-blockade on perioperative mortality in coronary surgery
ten Broecke et al.
Br J Anaesth 2003;90:27-31.
ABSTRACT | FULL TEXT  

The Impact of a Cardioprotective Protocol on the Incidence of Cardiac Complications After Aortic Abdominal Surgery
Licker et al.
Anesth. Analg. 2002;95:1525-1533.
ABSTRACT | FULL TEXT  

Beta-blockade and surgery
Prichard and Robin
Eur Heart J 2001;22:1253-1255.
ABSTRACT  

Intercurrent drug therapy and perioperative cardiovascular mortality in elective and urgent/emergency surgical patients{{dagger}}
Sear et al.
Br J Anaesth 2001;86:506-512.
ABSTRACT | FULL TEXT  

The Case for {beta}-Adrenergic Blockade as Prophylaxis Against Perioperative Cardiovascular Morbidity and Mortality
Selzman et al.
Arch Surg 2001;136:286-290.
ABSTRACT | FULL TEXT  

Editorial I: Peri-operative {beta}-blockade: a useful treatment that should be greeted with cautious enthusiasm
Howell et al.
Br J Anaesth 2001;86:161-164.
FULL TEXT